USANA Health Sciences Q1 Earnings Forecast Cut by Sidoti

USANA Health Sciences, Inc. (NYSE:USNA) – Equities research analysts at Sidoti reduced their Q1 2027 earnings per share estimates for shares of USANA Health Sciences in a report issued on Thursday, November 5th. Sidoti analyst A. Lebiedzinski now forecasts that the company will post earnings of $0.24 per share for the quarter, down from their previous estimate of $0.28. The consensus estimate for USANA Health Sciences’ current full-year earnings is $0.55 per share. Sidoti also issued estimates for USANA Health Sciences’ Q2 2027 earnings at $0.34 EPS, Q3 2027 earnings at $0.31 EPS, Q4 2027 earnings at $0.36 EPS, Q1 2028 earnings at $0.35 EPS, Q2 2028 earnings at $0.44 EPS, Q3 2028 earnings at $0.42 EPS and FY2028 earnings at $1.68 EPS.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, November 3rd. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.22). The business had revenue of $205.89 million for the quarter, compared to the consensus estimate of $217.42 million. USANA Health Sciences had a positive return on equity of 3.56% and a negative net margin of 2.34%.

A number of other equities research analysts have also commented on USNA. Weiss Ratings restated a “sell (d)” rating on shares of USANA Health Sciences in a report on Monday, September 21st. Wall Street Zen lowered shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Zacks Research cut USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 4th. Two research analysts have rated the stock with a Sell rating. According to MarketBeat, the stock has an average rating of “Sell”.

USANA Health Sciences Stock Up 1.7%

USANA Health Sciences stock opened at $13.86 on Monday. The company has a 50 day moving average of $14.60 and a 200-day moving average of $17.91. USANA Health Sciences has a twelve month low of $12.57 and a twelve month high of $23.59. The stock has a market capitalization of $256.13 million, a PE ratio of -12.05, a price-to-earnings-growth ratio of 2.17 and a beta of 0.66.

Hedge Funds Weigh In On USANA Health Sciences

Large investors have recently bought and sold shares of the company. Versant Capital Management Inc grew its stake in shares of USANA Health Sciences by 1,472.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,588 shares of the company’s stock worth $34,000 after acquiring an additional 1,487 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of USANA Health Sciences by 689.4% in the third quarter. GAMMA Investing LLC now owns 2,763 shares of the company’s stock worth $40,000 after purchasing an additional 2,413 shares in the last quarter. State of Wyoming bought a new stake in shares of USANA Health Sciences in the first quarter worth $57,000. State of Alaska Department of Revenue boosted its holdings in USANA Health Sciences by 79.3% during the third quarter. State of Alaska Department of Revenue now owns 11,950 shares of the company’s stock worth $172,000 after purchasing an additional 5,284 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new position in USANA Health Sciences during the second quarter worth $250,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.